Contact Us

SkunkWorx Bio

Avatar photo

SkunkWorx Bio was just announced as a winner of the Genewiz Week Grant Contest 

Uncategorized /

Genewiz stated, in the notification of the award, that “your abstract ‘Generation of a Companion Diagnostic For a Peptide Drug Conjugate’ has been selected as a winner of our GENEWIZ Week Grant Contest! Your application stood out among a competitive pool of abstracts due to its innovative approach, scientific merit, and exciting potential to impact […]

SkunkWorx Bio was just announced as a winner of the Genewiz Week Grant Contest  Read More »

SkunkWorx Bio was recently awarded an STTR grant from the NIH

Updates /

SkunkWorx Bio was recently awarded an STTR grant from the NIH to work on pediatric ATRT tumors in collaboration with Weill Cornell Medical Center.  These tumors are highly lethal and there are few available treatment options available. Patients have poor survival outcomes. SkunkWorx believes that its bispecific drug conjugate, 429-SM, is a first-in-class therapeutic and

SkunkWorx Bio was recently awarded an STTR grant from the NIH Read More »

Fill out the form below to get in touch

Skip to content